Validation of upregulated proteins in NF2−/− tumours revealed a markedly higher expression of Annexin-3 (ANXA3) compared to all datasets, but Solute carrier family 29 member 1 was not confirmed (Fig. 4d). The gene discussed is SLC12A9; the disease is neoplasm.